TELA

TELA Bio Inc

0.9418

Nov 11 • 3:59 PM ET +0.1418 (17.72%)

0.9716

Aftermarket • 7:34 PM ET +0.0298 (3.16%)

Healthcare Medical Devices USA Nano NASD

Nov 10, 6:53 PMTELA Bio beats Q3 loss expectations with $0.13 adjusted loss vs $0.19 consensus as cost cuts drive EBITDA improvement amid PRS-driven 8% revenue decline

Peers: ELUT IART XTNT AXGN RCEL BVS ORGO MDXG SMTI ANIK

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	42.51M
Enterprise Value	76.68M
Income	-41.88M
Sales	78.18M
Book/sh	-0.54
Cash/sh	0.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	218
IPO	Nov 08, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	0.54
P/B	-
P/C	1.88
P/FCF	-
EV/EBITDA	-
EV/Sales	0.98
Quick Ratio	0.45
Current Ratio	0.61
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.75
EPS next Y	-0.44
EPS next Q	-0.12
EPS this Y	19.94%
EPS next Y	33.15%
EPS next 5Y	25.43%
EPS past 3/5Y	32.78% 17.97%
Sales past 3/5Y	24.68% 34.54%
EPS Y/Y TTM	15.79%
Sales Y/Y TTM	1.46%
EPS Q/Q	14.89%
Sales Q/Q	-8.36%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	19.15% -5.21%

Insider Own	25.99%
Insider Trans	1.54%
Inst Own	43.43%
Inst Trans	-3.69%
ROA	-75.40%
ROE	-616.62%
ROIC	-
Gross Margin	67.19%
Oper. Margin	-40.63%
Profit Margin	-53.57%
SMA20	2.41%
SMA50	-8.50%
SMA200	10.66%
Trades

Shs Outstand	45.14M
Shs Float	33.41M
Short Float	1.73%
Short Ratio	2.66
Short Interest	0.58M
52W High	1.50 -37.21%
52W Low	0.50 87.95%
Volatility	19.87% 14.08%
ATR (14)	0.13
RSI (14)	50.53
Beta	1.46
Rel Volume	3.55
Avg Volume	217.91K
Volume	774,187

Perf Week	12.41%
Perf Month	-11.57%
Perf Quarter	38.91%
Perf Half Y	-1.90%
Perf YTD	-20.19%
Perf Year	-20.86%
Perf 3Y	-79.61%
Perf 5Y	-92.42%
Perf 10Y	-
Recom	1.40
Target Price	1.80
Prev Close	0.80
Price	0.94
Change %	17.72%

Consensus

Strong Buy

Avg. Price Target

$1.80

Implied Upside

+91.1%

Analysts7incl. previous ratings

Rating Distribution6 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 25, 2026	Initiated	CCraig Hallum	Buy	$2	+112.4%
Mar 21, 2025	Downgrade	PPiper Sandler	Overweight → Neutral	$5 → $2	+112.4%
May 31, 2022	Initiated	LLake Street	Buy	$17	+1,705.1%
Dec 03, 2019	Initiated	PPiper Jaffray	Overweight
Dec 03, 2019	Initiated	JJMP Securities	Mkt Outperform
Dec 03, 2019	Initiated	JJefferies	Buy
Dec 03, 2019	Initiated	CCanaccord Genuity	Buy

Nov-10-26 05:51PM	TELA Bio Beats On Cost Cuts, But Shrinking Revenue And A Thinning Cash Cushion Define The Quarter (Earnings Whispers) -7.47% +17.72%
04:00PM	TELA Bio Reports Third Quarter 2026 Financial Results (GlobeNewswire)
Nov-06-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.13% +5.44%
Nov-03-26 11:46AM	TELA Bio Heads Into Q3 With New CEO, No Guidance And A Shrinking Cash Cushion (Earnings Whispers)
Oct-27-26 04:05PM	TELA Bio to Announce Third Quarter 2026 Financial Results (GlobeNewswire)
08:00AM	Loading…
Oct-05-26 08:00AM	TELA Bio Announces 510(k) Clearance for Liora Monofilament Scaffold for Soft Tissue Reinforcement (GlobeNewswire)
Aug-31-26 07:00AM	TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative (GlobeNewswire) +5.43%
Aug-11-26 01:03AM	TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... (GuruFocus.com) -15.05%
Aug-10-26 04:05PM	TELA Bio Reports Second Quarter 2026 Financial Results (GlobeNewswire) +6.91%
Aug-07-26 09:24AM	Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside (GuruFocus.com)
Aug-05-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.01%
Aug-04-26 07:00AM	TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director (GlobeNewswire) +22.51%
Jul-29-26 04:05PM	TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-20-26 04:05PM	TELA Bio to Announce Second Quarter 2026 Financial Results (GlobeNewswire)
May-13-26 01:01AM	TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ... (GuruFocus.com) -5.88%
04:05PM	Loading…
May-12-26 04:05PM	TELA Bio Reports First Quarter 2026 Financial Results (GlobeNewswire) +5.14%
May-11-26 09:23AM	What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings (GuruFocus.com)
May-07-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.11% -7.27%
Apr-30-26 04:43PM	TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues (GlobeNewswire) +13.07%
Apr-21-26 04:05PM	TELA Bio to Announce First Quarter 2026 Financial Results (GlobeNewswire)
Mar-24-26 11:02PM	TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... (GuruFocus.com) -8.27% -9.35%
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-23-26 09:23AM	TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.66%
Mar-10-26 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire) -7.35%
Mar-02-26 08:15AM	Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates (Zacks)
Feb-26-26 12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-20-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -9.76% +6.77%
Jan-23-26 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-12-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-25 08:30AM	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -8.47%
04:05PM	Loading…
Nov-17-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.08%
Nov-14-25 12:03AM	TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com) -9.97%
Nov-13-25 05:15PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:21PM	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
04:01PM	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility (GlobeNewswire)
Nov-12-25 08:30AM	Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:36AM	TELA Bio Inc (TELA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-25 07:10PM	Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.98%
Nov-04-25 08:30AM	TELA Bio to Announce Third Quarter 2025 Financial Results (GlobeNewswire) -5.84%
Nov-03-25 04:05PM	TELA Bio Appoints William Plovanic to Board of Directors (GlobeNewswire) +11.38%
Oct-09-25 04:05PM	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran (GlobeNewswire)
Aug-12-25 03:06AM	TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) -13.98%
Aug-11-25 07:00PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +8.14%
04:03PM	TELA Bio Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 05:00PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:31AM	TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-07-25 09:10AM	Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-06-25 08:15AM	Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.11%
Jul-29-25 08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
Jul-23-25 04:03PM	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-21-25 04:03PM	TELA Bio to Announce Second Quarter 2025 Financial Results (GlobeNewswire) -7.04%
Jun-07-25 11:01PM	Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
Jun-06-25 04:05PM	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-25 04:05PM	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair (GlobeNewswire) +10.56% +19.75%
Jun-02-25 08:30AM	TELA Bio Appoints Jeffrey Blizard as President (GlobeNewswire)
May-22-25 04:05PM	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-09-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.04% -6.48%
03:41AM	TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:43AM	TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Apr-21-25 04:28PM	TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... (GuruFocus.com) -6.92% +5.62%
Apr-17-25 04:05PM	TELA Bio to Announce First Quarter 2025 Financial Results (GlobeNewswire)
Mar-31-25 07:00AM	TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex PRS for Plastic and Reconstructive Surgery (GlobeNewswire)
Mar-21-25 02:26PM	TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover (GuruFocus.com) -37.18%
12:05PM	Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 10:05PM	TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy (SeekingAlpha)
10:04PM	TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:50PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-27-25 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-21-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-24 04:05PM	TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:12PM	Q3 2024 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
02:29AM	TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-07-24 06:20PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:49AM	What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings (GuruFocus.com)
Nov-01-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-25-24 09:05PM	OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com) +10.85%
Oct-24-24 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Oct-23-24 08:07AM	TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.43%
Oct-22-24 04:05PM	TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Oct-17-24 04:05PM	TELA Bio to Announce Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-01-24 09:02PM	Orbimed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com)
Aug-12-24 05:20PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -22.94%
04:05PM	TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance (GlobeNewswire)
Aug-09-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-24 04:05PM	TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-22-24 04:05PM	TELA Bio to Announce Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-04-24 04:05PM	TELA Bio Appoints Jeffrey Blizard to its Board of Directors (GlobeNewswire)
May-20-24 04:03PM	TELA Bio Appoints Greg Firestone as Chief Commercial Officer (GlobeNewswire)
May-13-24 11:01AM	TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.80%
03:51PM	TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth (GuruFocus.com)
10:15AM	Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating (MT Newswires)
May-09-24 04:05PM	TELA Bio Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 04:10PM	MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript (Insider Monkey)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Capper Joseph H	Director	Sep 16 '26	Buy	1.17	50,000	58,265	154,827	Sep 18 04:30 PM
Capper Joseph H	Director	Sep 17 '26	Buy	1.22	25,000	30,530	179,827	Sep 18 04:30 PM
Capper Joseph H	Director	Sep 15 '26	Buy	1.06	50,000	52,940	104,827	Sep 16 06:46 PM
Capper Joseph H	Director	Sep 14 '26	Buy	1.02	25,000	25,502	54,827	Sep 16 06:46 PM
Getz Heather C	Chief Executive Officer	Aug 17 '26	Buy	0.66	12,500	8,311	532,500	Aug 19 04:10 PM
Getz Heather C	Chief Executive Officer	Aug 14 '26	Buy	0.70	15,000	10,467	520,000	Aug 17 04:32 PM
EW HEALTHCARE PARTNERS FUND 2,	10% Owner	Nov 17 '25	Buy	1.11	3,604,000	4,000,440	7,714,709	Nov 17 04:26 PM

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

PresidentMr. Jeffrey Blizard

M.B.A.Ms. Heather C. Getz CPA

VPMs. Megan Smeykal

Chief Technology OfficerMr. Paul Talmo

General Counsel & Corporate SecretaryMr. D. Taylor Ocasio

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

TELA

TELA Bio Inc

Upgrade your Finviz experience

All the Features.
Half the Price.